Research
Hormonal
Bioactive peptides (BAPs) derived from dietary proteins can survive digestion, interact with GI receptors, and exert physiological effects such as lowering blood pressure or regulating appetite, even if systemic absorption is limited.
Consuming fermented dairy products or specific protein hydrolysates may provide bioactive peptides that help regulate blood pressure and appetite. These peptides can work by interacting with your gut lining or being absorbed in small amounts, offering benefits beyond basic nutrition.
GoodSupportsHIGH confidence
Therefore, the physiological effects of BAPs may be due to one of efficacy at a very low concentration, an accumulation of an active concentration in certain tissues (e.g., aorta), an interaction with gut wall or luminal receptors without being absorbed, or a combination of these actions.
Why this rating
Supported by specific studies on fermented dairy products and peptide absorption in animal and human models.
Source
Dietary Proteins as Determinants of Metabolic and Physiologic Functions of the Gastrointestinal Tract
Alireza Jahan-Mihan et al. · Nutrients · 2011
DOI 10.3390/nu3050574
narrative_reviewCited 227×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Dietary proteins regulate gastrointestinal physiology and metabolic functions (including food intake, gastric emptying, and hormone release) through source-specific interactions with the GI tract, distinct from their role as amino acid sources.Good
- Different protein sources (e.g., casein vs. whey) have distinct effects on gastric emptying rates and satiety due to their physico-chemical properties and digestion kinetics.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →